The agenda for the 22 July 2015 TC meeting is now available. The Commission will consider the following technologies:

• Voriconazole (Vfend) - new indication
• Rifaximin (Tixtar/Targaxan) - new indication
• Ruxolitinib phosphate (Jakavi) - new indication
• Bedaquiline fumarate (Sirturo) - new medicine
• Diphtheria, tetanus, pertussis (acellular, component), hepatitis B, poliomyelitis (inactivated) and Haemophilus influenzae Type b conjugate vaccine (adsorbed) (Hexyon) - new vaccine
• Simoctocog alfa (Nuwiq) - new blood product
• Cyclosporin (Ikervis) - new indication
• Agomelatine (Valdoxan) - review of ASMR

For more details, go to: http://www.has-sante.fr/portail/upload/docs/application/pdf/2015-07/ordre_du_jour_commission_transparence_22072015.pdf [French]